In 1985 Jankovic in particular advocated for the use of “neuroacanthocytosis” rather than of “choreoacanthocytosis” or “Levine-Critchley syndrome” to describe such cases [6], that in hindsight are characterized by the features of disease due to VPS13A mutations. This evidence concerns the gene VPS13A and Choreoacanthocytosis.